Lomustine Clinical Trials
11 recruitingDrug
Phase 26Phase 34Phase 13
Showing 1–11 of 11 trials
Recruiting
Phase 2
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Recurrent GlioblastomaProgressive Glioblastoma
National Cancer Institute (NCI)184 enrolled324 locationsNCT06325683
Recruiting
Phase 3
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Vastra Gotaland Region200 enrolled20 locationsNCT06419946
Recruiting
Phase 2Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Glioblastoma
Global Coalition for Adaptive Research2,250 enrolled63 locationsNCT03970447
Recruiting
Phase 3
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Children's Oncology Group225 enrolled103 locationsNCT05382338
Recruiting
Phase 3
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
First Progression of Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC411 enrolled43 locationsNCT05904119
Recruiting
Phase 1
Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Glioblastoma
University of California, Davis20 enrolled1 locationNCT07145112
Recruiting
Phase 2
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
Glioblastoma
The University of Texas Health Science Center at San Antonio25 enrolled1 locationNCT04863950
Recruiting
Phase 1Phase 2
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Glioblastoma Multiforme
VBI Vaccines Inc.98 enrolled12 locationsNCT03382977
Recruiting
Phase 2
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Glioblastoma
Philogen S.p.A.90 enrolled8 locationsNCT06336291
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Glioblastoma
Philogen S.p.A.142 enrolled15 locationsNCT04573192
Recruiting
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen464 enrolled8 locationsNCT06283927